Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stockholders' Deficit (Tables)

v3.19.2
Note 6 - Stockholders' Deficit (Tables)
6 Months Ended
Jun. 30, 2019
Notes Tables  
Nonvested Restricted Stock Shares Activity [Table Text Block]
   
Number of
Shares
   
Weighted-
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2018
   
127,500
    $
3.21
 
Granted
   
-
     
 
 
Vested
   
(127,500
)    
3.21
 
Forfeited
   
-
     
 
 
Outstanding at March 31, 2019
   
-
     
-
 
Granted
   
200,000
     
11.54
 
Vested
   
(16,668
)    
11.54
 
Forfeited
   
-
     
 
 
Outstanding at June 30, 2019
   
183,332
    $
11.54
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Number of
Shares
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining Life
(in Years)
   
Aggregate
Intrinsic
Value
 
                                 
Outstanding, December 31, 2018
   
2,235,000
    $
1.74
     
9.44
    $
23,100
 
Granted    
589,550
     
5.32
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Cancelled
   
-
     
-
     
 
     
 
 
Outstanding, June 30, 2019
   
2,824,550
    $
2.49
     
9.11
    $
34,496,387
 
                                 
Exercisable, June 30, 2019
   
662,938
    $
1.73
     
8.26
    $
8,597,191
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   
Number of
Shares
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining
Contractual
Term
(in Years)
   
Aggregate
Intrinsic
Value
 
                                 
Outstanding, December 31, 2018
   
776,350
    $
1.75
     
4.80
    $
-
 
Granted
   
924,581
     
9.73
     
 
     
 
 
Exercised    
(205,715
)    
3.00
     
 
     
2,407,008
 
Forfeited (cashless exercise)
   
(114,383
)    
5.15
     
 
     
 
 
Outstanding, June 30, 2019
   
1,380,833
    $
6.63
     
4.61
    $
11,148,662
 
                                 
Exercisable, June 30, 2019
   
1,380,833
    $
5.90
     
4.61
    $
12,148,662